BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · IEX Real-Time Price · USD
81.83
-0.75 (-0.91%)
May 8, 2024, 4:00 PM EDT - Market closed
BioMarin Pharmaceutical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1997 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 755.13 | 724.53 | 587.28 | 649.16 | 437.45 | 493.98 | 598.03 | 408.33 | 397.04 | 875.49 | Upgrade
|
Short-Term Investments | 318.68 | 567.01 | 426.6 | 416.23 | 316.36 | 590.33 | 797.94 | 381.35 | 195.58 | 69.71 | Upgrade
|
Cash & Cash Equivalents | 1,074 | 1,292 | 1,014 | 1,065 | 753.81 | 1,084 | 1,396 | 789.68 | 592.62 | 945.19 | Upgrade
|
Cash Growth | -16.86% | 27.39% | -4.83% | 41.33% | -30.48% | -22.33% | 76.78% | 33.25% | -37.30% | 20.45% | Upgrade
|
Receivables | 633.7 | 461.32 | 373.4 | 448.35 | 377.4 | 342.63 | 261.37 | 215.28 | 164.96 | 144.47 | Upgrade
|
Inventory | 1,107 | 894.08 | 776.67 | 698.55 | 680.28 | 530.87 | 475.78 | 355.13 | 271.68 | 199.45 | Upgrade
|
Other Current Assets | 141.39 | 104.52 | 110.44 | 129.93 | 130.66 | 98.4 | 74.04 | 61.71 | 60.38 | 108.52 | Upgrade
|
Total Current Assets | 2,956 | 2,751 | 2,274 | 2,342 | 1,942 | 2,056 | 2,207 | 1,422 | 1,090 | 1,398 | Upgrade
|
Property, Plant & Equipment | 1,066 | 1,073 | 1,035 | 1,032 | 1,011 | 948.68 | 896.7 | 798.77 | 704.21 | 523.52 | Upgrade
|
Long-Term Investments | 611.14 | 333.84 | 507.79 | 285.47 | 411.98 | 235.86 | 385.79 | 572.71 | 425.65 | 97.86 | Upgrade
|
Goodwill and Intangibles | 490.9 | 534.77 | 584.85 | 613.47 | 653.62 | 688.85 | 714.55 | 750.82 | 881.04 | 210.84 | Upgrade
|
Other Long-Term Assets | 1,717 | 1,682 | 1,602 | 1,574 | 671.43 | 497.52 | 428.95 | 479.6 | 628.84 | 245.53 | Upgrade
|
Total Long-Term Assets | 3,886 | 3,624 | 3,730 | 3,506 | 2,748 | 2,371 | 2,426 | 2,602 | 2,640 | 1,078 | Upgrade
|
Total Assets | 6,842 | 6,375 | 6,005 | 5,848 | 4,690 | 4,427 | 4,633 | 4,024 | 3,729 | 2,475 | Upgrade
|
Accounts Payable | 683.15 | 572.96 | 498.27 | 492.55 | 570.62 | 437.29 | 401.92 | 370.51 | 392.51 | 231.84 | Upgrade
|
Current Debt | 493.88 | 0 | 0 | 0 | 361.88 | 0 | 360.95 | 22.48 | 0 | 0 | Upgrade
|
Other Current Liabilities | 0 | 15.93 | 48.23 | 0 | 0 | 85.95 | 53.65 | 46.33 | 52.95 | 3.9 | Upgrade
|
Total Current Liabilities | 1,177 | 588.88 | 546.5 | 492.55 | 932.5 | 523.24 | 816.52 | 439.31 | 445.46 | 235.74 | Upgrade
|
Long-Term Debt | 593.1 | 1,083 | 1,079 | 1,075 | 486.24 | 830.42 | 813.52 | 660.76 | 662.29 | 642.9 | Upgrade
|
Other Long-Term Liabilities | 119.94 | 100.02 | 113.53 | 174.33 | 148.92 | 105.53 | 194.42 | 157.34 | 220.78 | 68.84 | Upgrade
|
Total Long-Term Liabilities | 713.03 | 1,183 | 1,193 | 1,249 | 635.16 | 935.95 | 1,008 | 818.11 | 883.06 | 711.75 | Upgrade
|
Total Liabilities | 1,890 | 1,772 | 1,739 | 1,742 | 1,568 | 1,459 | 1,824 | 1,257 | 1,329 | 947.49 | Upgrade
|
Total Debt | 1,087 | 1,083 | 1,079 | 1,075 | 848.12 | 830.42 | 1,174 | 683.24 | 662.29 | 642.9 | Upgrade
|
Debt Growth | 0.36% | 0.37% | 0.37% | 26.77% | 2.13% | -29.29% | 71.90% | 3.16% | 3.02% | -1.93% | Upgrade
|
Retained Earnings | -621.55 | -789.2 | -930.76 | -861.61 | -1,720.71 | -1,694.13 | -1,637.55 | -1,520.51 | -1,021.57 | -849.77 | Upgrade
|
Comprehensive Income | -28.79 | -3.87 | 14.43 | -16.14 | 20.16 | 5.27 | -22.96 | 12.82 | 21.03 | 27.47 | Upgrade
|
Shareholders' Equity | 4,952 | 4,603 | 4,266 | 4,106 | 3,122 | 2,968 | 2,809 | 2,766 | 2,401 | 1,528 | Upgrade
|
Net Cash / Debt | -13.16 | 208.52 | -65.2 | -9.76 | -94.31 | 253.89 | 221.5 | 106.44 | -69.67 | 302.29 | Upgrade
|
Net Cash / Debt Growth | - | - | - | - | - | 14.62% | 108.10% | - | - | 134.05% | Upgrade
|
Net Cash Per Share | -0.07 | 1.10 | -0.36 | -0.05 | -0.53 | 1.43 | 1.27 | 0.64 | -0.44 | 2.07 | Upgrade
|
Working Capital | 1,779 | 2,163 | 1,728 | 1,850 | 1,010 | 1,533 | 1,391 | 982.48 | 644.18 | 1,162 | Upgrade
|
Book Value Per Share | 26.36 | 24.85 | 23.33 | 22.71 | 17.44 | 16.76 | 16.10 | 16.67 | 15.00 | 10.44 | Upgrade
|